{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:12:18Z","timestamp":1781100738416,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ijpharm.2009.08.021","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T09:58:18Z","timestamp":1251367098000},"page":"277-290","source":"Crossref","is-referenced-by-count":69,"title":["Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain"],"prefix":"10.1016","volume":"382","author":[{"given":"Samantha","family":"Pillay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viness","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya E.","family":"Choonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valence M.K.","family":"Ndesendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Danckwerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny E.","family":"Iyuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2009.08.021_bib1","first-page":"801","article-title":"Nanotechnology: a revolution in the making","volume":"75","author":"Ahmad","year":"2005","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib2","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ejps.2007.05.021","article-title":"Tumor targeted nanoparticles for cancer therapy","volume":"32","author":"Bilensoy","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1243\/095441102321032166","article-title":"Characterization of microfeatures in selective laser sintered drug delivery devices","volume":"216","author":"Cheah","year":"2002","journal-title":"Proc. Inst. Mech. Eng. Part H: J. Eng. Med."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib4","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.clinthera.2005.11.016","article-title":"A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease","volume":"27","author":"Chen","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib5","first-page":"42","article-title":"Fabricating facial prosthesis models using rapid prototyping tools","volume":"11","author":"Chua","year":"2000","journal-title":"Integr. Manuf. Syst. (Int. J. Manuf. Technol. Manage.)"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO;2-1","article-title":"Design and fabrication of cast orthopedic implants with freeform surface textures from 3D printed ceramic shell","volume":"53","author":"Curodeau","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.progpolymsci.2007.05.011","article-title":"Emerging applications of polymersomes in drug delivery: from molecular dynamics to shrinkage of tumors","volume":"32","author":"Discher","year":"2007","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2005.07.028","article-title":"Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization","volume":"314","author":"Elkharraz","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.addr.2006.09.011","article-title":"Nanomedicine: developing smarter therapeutic and diagnostic modalities","volume":"58","author":"Farokhzad","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1023\/A:1018971630036","article-title":"Determination of glass transition temperatures of some new methyl methacrylate copolymers using modulated temperature differential scanning calorimetry (MTDSC)","volume":"16","author":"Ferrero","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.semcdb.2007.09.004","article-title":"Restorative cell therapy for Parkinson's disease: a quest for the perfect cell","volume":"18","author":"Hall","year":"2007","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib12","first-page":"484","article-title":"Treatment of Parkinson's disease","volume":"7","author":"Hely","year":"2000","journal-title":"J. Clin. Sci."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1476-5381.1989.tb11887.x","article-title":"Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour","volume":"96","author":"Hutson","year":"1989","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib14","first-page":"1522","article-title":"CT-generated porous hydroxyapatite orbital floor prosthesis as a prototype bioimplant","volume":"18","author":"Levy","year":"1997","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0266-3538(02)00226-9","article-title":"Morphology, thermal and mechanical behavior of polyamide 6\/layered-silicate nanocomposites","volume":"63","author":"Liu","year":"2003","journal-title":"Comp. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nbd.2008.07.019","article-title":"Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes","volume":"32","author":"Marin","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00006534-199908000-00003","article-title":"Treatment of large complex cranial bone defects by using hydroxyapatite ceramic implants","volume":"104","author":"Ono","year":"1999","journal-title":"Plastic Reconstr. Surg."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1358\/dot.1998.34.2.485183","article-title":"Advances in the treatment of Parkinson's disease","volume":"34","author":"Pahwa","year":"1998","journal-title":"Drugs Today"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00415-005-0918-5","article-title":"Psychotic symptoms in Parkinson's disease: from description to etiology","volume":"252","author":"Papapetropoulos","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpharm.2004.11.010","article-title":"Preparation and characterization of triclosan nanoparticles for periodontal treatment","volume":"294","author":"Pi\u00f1\u00f3n-Segundo","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.colsurfa.2008.04.003","article-title":"Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification\u2013diffusion technique using ethanol as surface agent","author":"Poletto","year":"2008","journal-title":"Colloid Surf. A: Physicochem. Eng. Aspects"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J","article-title":"Fabrication of porous calcium polyphosphate implants by solid freeform fabrication: a study of processing parameters and in vitro degradation characteristics","volume":"56","author":"Porter","year":"2001","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib23","first-page":"248","article-title":"Modulated differential scanning calorimetry\u2014a new way forward in materials characterization","volume":"1","author":"Reading","year":"1993","journal-title":"Trends Polym. Sci."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0168-3659(00)00367-9","article-title":"Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterization and in vivo evaluation","volume":"70","author":"Redhead","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0303-8467(93)90126-2","article-title":"The influence of a standard meal on Sinemet\u00ae CR absorption in patients with Parkinson's disease","volume":"95","author":"Roos","year":"1993","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0032-3861(01)00612-7","article-title":"Characterization of polyanhydride microsphere degradation by DSC","volume":"43","author":"Sandor","year":"2002","journal-title":"Polymer"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pneurobio.2006.11.009","article-title":"Advances in the treatment of Parkinson's disease","volume":"81","author":"Singh","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijpharm.2009.08.021_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1353-8020(96)00038-7","article-title":"Positron emission tomography (PET) measurements of striatal D2 receptors in untreated Parkinson's disease patients with follow-up after 6 and 12 months\u2019 treatment with Sinemet\u00ae or Sinemet\u00ae CR","volume":"3","author":"Uitti","year":"1997","journal-title":"Parkinson's Related Disorders"},{"key":"10.1016\/j.ijpharm.2009.08.021_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/NRL.0b013e318158e47d","article-title":"Medications for Parkinson's disease: patient and family fact sheet","volume":"13","author":"Whitney","year":"2007","journal-title":"Neurologist"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517309005699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517309005699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T09:55:15Z","timestamp":1545040515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517309005699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0378517309005699"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2009.08.021","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}